Article
IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist.
Oncogene - 1 May 2022
Baker Kevin, O'Donnell Charlotte, Bendix Maura, Keogh Samuel, Byrne James, O'Riordain Michael, Neary Peter, Houston Aileen, Brint Elizabeth
Abstract excerpt
The IL-36 cytokines are a recently described subset of the IL-1 family of cytokines, shown to play a role in the pathogenesis of intestinal diseases such as Inflammatory Bowel Disease (IBD). Given the link between IBD and colitis -associated cancer, as well as the involvement of other IL-1 family members in intestinal tumorigenesis, the aim of this work was to investigate whether IL-36 cytokines play a role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
